Re: Patel et al: Oral Antithrombotic Medication Is Associated with Improved Visual Acuity Outcomes in Eyes with Neovascular Age-Related Macular Degeneration.
作者信息
Gabrielle Pierre-Henry, Creuzot-Garcher Catherine
机构信息
Ophthalmology Department, Dijon University Hospital, Dijon, France.
出版信息
Ophthalmol Sci. 2025 Jun 3;5(6):100840. doi: 10.1016/j.xops.2025.100840. eCollection 2025 Nov-Dec.
Abstract
摘要
相似文献
1
Re: Patel et al: Oral Antithrombotic Medication Is Associated with Improved Visual Acuity Outcomes in Eyes with Neovascular Age-Related Macular Degeneration.回复：帕特尔等人：口服抗血栓药物与新生血管性年龄相关性黄斑变性患者的视力改善结果相关。
Ophthalmol Sci. 2025 Jun 3;5(6):100840. doi: 10.1016/j.xops.2025.100840. eCollection 2025 Nov-Dec.
2
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
3
Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration.抗血管内皮生长因子生物类似药治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD015804. doi: 10.1002/14651858.CD015804.pub2.
4
Macular Atrophy in Neovascular Age-related Macular Degeneration: A Systematic Review and Meta-analysis.新生血管性年龄相关性黄斑变性中的黄斑萎缩：一项系统评价和荟萃分析
Ophthalmol Retina. 2025 Jul;9(7):625-644. doi: 10.1016/j.oret.2025.01.011. Epub 2025 Jan 20.
5
Persistence of Retinal Fluid after Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后视网膜下液的持续存在：一项系统评价和荟萃分析
Ophthalmol Retina. 2025 Jan 20. doi: 10.1016/j.oret.2025.01.010.
6
Photodynamic therapy for neovascular age-related macular degeneration.光动力疗法治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2000(2):CD002030. doi: 10.1002/14651858.CD002030.
7
Photodynamic therapy for neovascular age-related macular degeneration.光动力疗法治疗新生血管性年龄相关性黄斑变性
Cochrane Database Syst Rev. 2001(3):CD002030. doi: 10.1002/14651858.CD002030.
8
Comparable choroidal thickness between treated eyes and untreated fellow-eyes in patients with unilateral neovascular AMD: a paired-eyes comparative study.单侧新生血管性年龄相关性黄斑变性患者治疗眼与未治疗对侧眼脉络膜厚度的比较：配对眼比较研究。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 8. doi: 10.1007/s00417-025-06751-7.
9
Macular translocation for neovascular age-related macular degeneration.黄斑转位术治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2008 Oct 8(4):CD006928. doi: 10.1002/14651858.CD006928.pub2.
10
Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.老年人群中未受影响的第二眼新生血管性黄斑变性的早期无创性检测：EDNA 诊断准确性研究。
Health Technol Assess. 2022 Jan;26(8):1-142. doi: 10.3310/VLFL1739.
本文引用的文献
1
Oral Antithrombotic Medication Is Associated with Improved Visual Outcomes in Eyes with Submacular Hemorrhage from Wet Age-Related Macular Degeneration.口服抗血栓药物与湿性年龄相关性黄斑变性所致黄斑下出血患者的视力改善相关。
Ophthalmol Sci. 2025 Apr 14;5(5):100796. doi: 10.1016/j.xops.2025.100796. eCollection 2025 Sep-Oct.
2
Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration.手术、组织型纤溶酶原激活物、抗血管生成药物与年龄相关性黄斑变性研究：继发于年龄相关性黄斑变性的黄斑下出血的随机对照试验。
Ophthalmology. 2023 Sep;130(9):947-957. doi: 10.1016/j.ophtha.2023.04.014. Epub 2023 Apr 22.
3
Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study.抗栓药物在黄斑手术中围手术期出血的风险：一项全国性、前瞻性、多中心研究。
Acta Ophthalmol. 2020 Dec;98(8):e991-e997. doi: 10.1111/aos.14434. Epub 2020 Apr 12.
4
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients.玻璃体视网膜手术中的抗血小板和抗凝剂：一项涉及804例患者的前瞻性多中心研究。
Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1359. doi: 10.1007/s00417-018-3969-x. Epub 2018 Mar 30.
5
Statistics notes: Analysing controlled trials with baseline and follow up measurements.统计学笔记：分析具有基线和随访测量的对照试验。
BMJ. 2001 Nov 10;323(7321):1123-4. doi: 10.1136/bmj.323.7321.1123.
Zotero 插件